• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.44% Nasdaq Down0.37%

    More On COV.V



    News & Info


    Analyst Coverage


    • Major Holders
    • Insider Transactions
    • Insider Roster


    Covalon Technologies Ltd. (COV.V)

    0.90 Up 0.06(7.14%) 3:49PM EST
    ProfileGet Profile for:
    Covalon Technologies Ltd.
    405 Britannia Road East
    Suite 106
    Mississauga, ON L4Z 3E6
    Canada - Map
    Phone: 905-568-8400
    Fax: 905-568-5200
    Website: http://www.covalon.com

    Index Membership:N/A
    Full Time Employees:N/A

    Business Summary 

    Covalon Technologies Ltd. develops, licenses, and sells medical technologies. It operates in two segments, Advanced Wound Care and Specialized Medical Device Coatings. The company provides advanced wound care products comprising ColActive Plus Ag advanced wound care dressings; ColActive Transfer wound contact layers; CovaStat bio-active absorbable hemostatic sponges; and CovaSorb bio-active absorbent foam replacement dressings. It also offers IV Clear and SurgiClear antimicrobial silicone dressings. In addition, the company provides medical coatings that deliver infection control, therapeutic delivery, and lubricity, as well as CovaCoat medical coatings that offers photochemical process for covalently linking coating molecules to various medical device surfaces; and SilverCoat antimicrobial silicone foley catheters. Further, it offers process and manufacturing equipment validation assistance and on-site training services; and professional services, including feasibility studies, product formulation, prototype testing, validation, and manufacturing. The company sells its technologies and products to medical companies and distributors worldwide. Covalon Technologies Ltd. is headquartered in Mississauga, Canada.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Covalon Technologies Ltd.

    Key Executives 
    Mr. Abe Schwartz ,
    Chairman of The Board, Advisor and Member of Audit Committee
    Mr. Brian E. Pedlar ,
    Chief Exec. Officer, Pres and Director
    Dr. Valerio DiTizio , 47
    Co-Founder and Chief Science Officer
    Kim Crooks ,
    VP of Operations
    John Hands ,
    Sr. Director of Global Marketing
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in CAD.